acyl derivatives of 5-(2-(4-(1,2 benzisothiazole3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-di hydro-2H-indol-2-one having neuroleptic activity

Details for Australian Patent Application No. 2003269331 (hide)

Owner Pfizer Products Inc.

Inventors Colon-Cruz, Roberto; Norris, Timothy

Agent Spruson & Ferguson

Pub. Number AU-B-2003269331

PCT Number PCT/IB03/04519

PCT Pub. Number WO2004/037819

Priority 60/420,843 24.10.02 US

Filing date 13 October 2003

Wipo publication date 13 May 2004

Acceptance publication date 18 February 2010

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

15 January 2004 Complete Application Filed

  Priority application(s): 60/420,843 24.10.02 US

17 June 2004 Application Open to Public Inspection

  Published as AU-B-2003269331

18 February 2010 Application Accepted

  Published as AU-B-2003269331

17 June 2010 Standard Patent Sealed

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003269332-METHOD AND SYSTEM FOR MULTIPLICATION OF BINARY NUMBERS

2003269330-BOTTLE NECK AND CONTAINER COMPRISING THE SAME